HMGB2 and neoplasm: Our future goals include performing mechanistic studies of HMGB2 functions using in vitro and in vivo models, including the elucidation of the crosstalk between HMGB2 expression in tumor cells and components of the TME in the immune response following immunogenic cell death induced by current treatment modalities.